Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1985 3
1986 1
1987 1
2004 1
2005 2
2007 1
2008 3
2009 1
2010 1
2011 2
2012 1
2013 1
2015 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grünhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Dürk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W; Study group indolent Lymphomas (StiL). Rummel MJ, et al. Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20. Lancet. 2013. PMID: 23433739 Clinical Trial.
[HPV associated diseases: More than warts and cervical carcinoma].
Heinrich B, Brudler O, Bangerter M. Heinrich B, et al. Among authors: brudler o. MMW Fortschr Med. 2015 May 13;157(9):41-4. doi: 10.1007/s15006-015-3082-6. MMW Fortschr Med. 2015. PMID: 26012825 Review. German. No abstract available.
[Anemia: from symptoms to diagnosis and therapy].
Heinrich B, Schrembs I, Brudler O, Bangerter M. Heinrich B, et al. Among authors: brudler o. MMW Fortschr Med. 2009 Nov 26;151(48):31-5; quiz 36. MMW Fortschr Med. 2009. PMID: 20085059 Review. German. No abstract available.
Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer.
Stemmler HJ, diGioia D, Freier W, Tessen HW, Gitsch G, Jonat W, Brugger W, Kettner E, Abenhardt W, Tesch H, Hurtz HJ, Rösel S, Brudler O, Heinemann V. Stemmler HJ, et al. Among authors: brudler o. Br J Cancer. 2011 Mar 29;104(7):1071-8. doi: 10.1038/bjc.2011.86. Epub 2011 Mar 15. Br J Cancer. 2011. PMID: 21407218 Free PMC article. Clinical Trial.
High efficacy and low toxicity of weekly docetaxel given as first-line treatment for metastatic breast cancer.
Stemmler J, Mair W, Stauch M, Papke J, Deutsch G, Abenhardt W, Dorn B, Kentenich C, Malekmohammadi M, Jackisch C, Leinung S, Brudler O, Vehling-Kaiser U, Stamp J, Heinemann V. Stemmler J, et al. Among authors: brudler o. Oncology. 2005;68(1):71-8. doi: 10.1159/000084823. Epub 2005 Mar 12. Oncology. 2005. PMID: 15809523 Free article. Clinical Trial.
[Medical treatment of cancer in the elderly].
Bangerter M, Heinrich B, Brudler O. Bangerter M, et al. Among authors: brudler o. MMW Fortschr Med. 2004 Sep 30;146(40):30-2. MMW Fortschr Med. 2004. PMID: 15529665 Review. German.
Limited clinical relevance of imaging techniques in the follow-up of patients with advanced chronic lymphocytic leukemia: results of a meta-analysis.
Eichhorst BF, Fischer K, Fink AM, Elter T, Wendtner CM, Goede V, Bergmann M, Stilgenbauer S, Hopfinger G, Ritgen M, Bahlo J, Busch R, Hallek M; German CLL Study Group (GCLLSG). Eichhorst BF, et al. Blood. 2011 Feb 10;117(6):1817-21. doi: 10.1182/blood-2010-04-282228. Epub 2010 Dec 7. Blood. 2011. PMID: 21139079 Free article.
21 results